Peel Hunt Reiterates Buy Rating for Clinigen Group PLC (CLIN)
Clinigen Group PLC (LON:CLIN)‘s stock had its “buy” rating reissued by equities research analysts at Peel Hunt in a research report issued to clients and investors on Tuesday. They currently have a GBX 1,000 ($12.19) price objective on the stock. Peel Hunt’s price target would indicate a potential upside of 33.33% from the stock’s previous close.
A number of other analysts have also recently weighed in on CLIN. Stifel Nicolaus reissued a “buy” rating and set a GBX 800 ($9.75) target price on shares of Clinigen Group PLC in a report on Wednesday, September 28th. Numis Securities Ltd reissued a “buy” rating on shares of Clinigen Group PLC in a report on Friday, June 24th. Finally, N+1 Singer reissued a “buy” rating and set a GBX 800 ($9.75) target price on shares of Clinigen Group PLC in a report on Wednesday, September 28th. Five research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of GBX 856.60 ($10.44).
Shares of Clinigen Group PLC (LON:CLIN) opened at 750.00 on Tuesday. The stock’s market cap is GBX 859.49 million. Clinigen Group PLC has a 12-month low of GBX 492.75 and a 12-month high of GBX 793.50. The company’s 50-day moving average is GBX 694.15 and its 200-day moving average is GBX 611.62.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/peel-hunt-reiterates-buy-rating-for-clinigen-group-plc-clin.html
The company also recently disclosed a dividend, which will be paid on Friday, November 25th. Investors of record on Thursday, November 3rd will be issued a GBX 2.70 ($0.03) dividend. This represents a dividend yield of 0.38%. The ex-dividend date is Thursday, November 3rd. This is a boost from Clinigen Group PLC’s previous dividend of $1.30.
About Clinigen Group PLC
Clinigen Group plc is a United Kingdom-based global pharmaceutical and services company. The Company consists of four businesses that provide medicines to patients with unmet needs, through clinical trials, licensed and unlicensed supply. It operates through four segments: Clinigen Clinical Trial Services (CTS), Idis Managed Access (MA), Idis Global Access (GA) and Clinigen Specialty Pharmaceuticals (SP).
Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.